A significant positive correlation between TGFBI levels and the expression of epithelial to mesenchymal transition (EMT) markers was also observed (ρ = 0.65, 95%CI: 0.59–0.71, p < 0.01) (Figure S6 B), which indicated that TGFBI might induce ovarian cancer cells to lose adhesive epithelial phenotype and acquire movable features of mesenchyme. The gene discussed is TGFBI; the disease is ovarian carcinoma.